ABBV Market Sentiment: 28 Analysts See Upside in AbbVie Inc

AbbVie Inc's (ABBV) market sentiment signals indicate an overall positive outlook from analysts. At close on July 29, the stock price was $257.41, down 2.24% from the previous day's close of $255.82.

The analyst consensus is 'Overweight,' with 28 analysts having expressed this view. The average price target among these analysts is $254, representing a potential upside of 0.6%. However, Barclays has set a higher target at $300, while UBS has the lowest target at $190.

Absent from the market sentiment signals are options flow and insider activity data. The short interest in AbbVie shares stands at 1.4%, which is considered bullish given its declining trend. Recent analyst actions include a maintenance of the 'Overweight' rating by Barclays, with Emily Field raising her price target to $275 from $273.

Canaccord Genuity's Gary Nachman also maintained his Buy rating on July 22, with a revised target of $282 from $273. Overall, AbbVie's market sentiment suggests a mix of caution and optimism among analysts.